HYOGO, Japan I July 8, 2025 I JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) today announced that it has entered into a license agreement with Alexion, ...

I Taiho Pharmaceutical Co., Ltd. announced that the results of a phase III, randomized, placebo-controlled, double-blind and open-label, ...

JERSEY CITY, NJ, USA I July 7, 2025 I Celltrion USA today announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing ...

I NYB.AI and Pnaseer Inc. (Pnaseer) have announced a strategic partnership to accelerate the discovery of compounds that promote ...

I SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and ...

BASEL, Switzerland I July 8, 2025 I Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria ...

LEXINGTON, MA, USA I July 07, 2025 I Agenus Inc. (Nasdaq: AGEN) a leader in immuno-oncology innovation, today announced that its botensilimab and balstilimab ...

GENEVA, Switzerland I July 07, 2025 I Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced its ...

SHANGHAI, China I July 4, 2025 I Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing ...

Research published in Science Advances indicates that CVXGA is a promising intranasal vaccine candidate that is safe, immunogenic and potentially effective ...

TOKYO, Japan I July 7, 2025 I Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519, hereafter “Chugai”), and Gero PTE. LTD. (hereafter “Gero”), a Singapore-based ...

“As the first orally administered on-demand therapy for HAE attacks, EKTERLY provides patients and physicians with an important and welcome advance in HAE treatment options,” said Anthony J. Castaldo, ...